Bionano Genomics, Inc.
BNGO
$1.18
-$0.02-1.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.27% | -167.67% | 60.58% | 80.78% | 57.74% |
| Total Depreciation and Amortization | -3.46% | -4.99% | -2.49% | -57.27% | -20.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -37.51% | 120.50% | -87.91% | -95.15% | 149.56% |
| Change in Net Operating Assets | 13.89% | -131.09% | -86.96% | -184.66% | 82.50% |
| Cash from Operations | -33.93% | -106.80% | 35.81% | 55.53% | 83.38% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 591.31% | 138.80% | 33.77% | 13.13% | -93.11% |
| Cash from Investing | 591.31% | 138.80% | 33.77% | 13.13% | -93.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -577.67% | 98.68% | 99.11% | -20.56% | 94.12% |
| Issuance of Common Stock | -79.94% | -94.71% | -73.95% | 27.96% | -74.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 75.00% | 96.95% | 84.11% | 61.55% | 98.36% |
| Cash from Financing | -759.84% | -93.97% | -58.79% | 67.35% | 174.27% |
| Foreign Exchange rate Adjustments | 104.17% | 155.56% | 275.00% | -37.50% | -2,300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -980.95% | 106.78% | 281.00% | 96.07% | -101.11% |